Elgan Pharma Ltd.

About:

Elgan Pharma is a neonatology-focused company that develops a technology targeted at prevention of visual impairment in preterm infants.

Website: https://www.elganpharma.com/

Top Investors: European Innovation Council

Description:

Total Funding Amount:

$4.97M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nazareth, HaZafon, Israel

Founded Date:

2018-05-01

Founders:

Miki Olshansky, Stav Zeldis

Number of Employees:

1-10

Last Funding Date:

2023-07-19

IPO Status:

Private

Industries: